Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Response to Letter].
作者信息
Teragawa Hiroki, Uchimura Yuko, Oshita Chikage, Hashimoto Yu, Nomura Shuichi
机构信息
Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan.
出版信息
Diabetes Metab Syndr Obes. 2024 Oct 25;17:3989-3990. doi: 10.2147/DMSO.S499928. eCollection 2024.
Abstract
摘要
相似文献
1
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Response to Letter].糖尿病和非糖尿病血管痉挛性心绞痛患者的临床特征及主要不良心血管事件[对信件的回复]
Diabetes Metab Syndr Obes. 2024 Oct 25;17:3989-3990. doi: 10.2147/DMSO.S499928. eCollection 2024.
2
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Response to Letter].糖尿病和非糖尿病血管痉挛性心绞痛患者的临床特征及主要不良心血管事件[对信件的回复]
Diabetes Metab Syndr Obes. 2024 Aug 1;17:2911-2912. doi: 10.2147/DMSO.S487575. eCollection 2024.
3
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Letter].糖尿病和非糖尿病血管痉挛性心绞痛患者的临床特征及主要不良心血管事件[信函]
Diabetes Metab Syndr Obes. 2024 Jul 22;17:2735-2736. doi: 10.2147/DMSO.S486527. eCollection 2024.
4
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Letter].糖尿病和非糖尿病变异性心绞痛患者的临床特征及主要不良心血管事件[信函]
Diabetes Metab Syndr Obes. 2024 Oct 10;17:3725-3726. doi: 10.2147/DMSO.S497353. eCollection 2024.
5
Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis.低剂量阿司匹林对无明显冠状动脉狭窄的血管痉挛性心绞痛患者的临床影响；一项倾向评分匹配分析。
Int J Cardiol. 2016 Oct 15;221:161-6. doi: 10.1016/j.ijcard.2016.06.195. Epub 2016 Jun 28.
6
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina.患有血管痉挛性心绞痛的糖尿病和非糖尿病患者的临床特征及主要不良心血管事件
Diabetes Metab Syndr Obes. 2024 May 25;17:2135-2146. doi: 10.2147/DMSO.S462234. eCollection 2024.
7
Management of vasospastic angina.血管痉挛性心绞痛的治疗。
Heart. 2022 Dec 13;109(1):70-77. doi: 10.1136/heartjnl-2022-321268.
8
9
Vasospastic angina: a review on diagnostic approach and management.血管痉挛性心绞痛：诊断方法和治疗的综述。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241230400. doi: 10.1177/17539447241230400.
10
Pharmacotherapy of Vasospastic Angina.变异性心绞痛的药物治疗
J Cardiovasc Pharmacol Ther. 2016 Sep;21(5):439-51. doi: 10.1177/1074248416640161. Epub 2016 Apr 13.
本文引用的文献
1
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Letter].糖尿病和非糖尿病变异性心绞痛患者的临床特征及主要不良心血管事件[信函]
Diabetes Metab Syndr Obes. 2024 Oct 10;17:3725-3726. doi: 10.2147/DMSO.S497353. eCollection 2024.
2
Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina.患有血管痉挛性心绞痛的糖尿病和非糖尿病患者的临床特征及主要不良心血管事件
Diabetes Metab Syndr Obes. 2024 May 25;17:2135-2146. doi: 10.2147/DMSO.S462234. eCollection 2024.
3
JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction.《日本循环学会/心血管介入治疗学会/日本心脏病学会2023年血管痉挛性心绞痛（冠状动脉痉挛性心绞痛）和冠状动脉微血管功能障碍诊断与治疗指南重点更新》
Circ J. 2023 May 25;87(6):879-936. doi: 10.1253/circj.CJ-22-0779. Epub 2023 Apr 6.
4
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的共识报告：2 型糖尿病患者高血糖管理。
Diabetologia. 2022 Dec;65(12):1925-1966. doi: 10.1007/s00125-022-05787-2. Epub 2022 Sep 24.
5
Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA.在INOCA 患者中，OCT 界定的冠状动脉形态与冠状动脉功能异常之间的预后关联。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):606-618. doi: 10.1016/j.jcin.2020.12.025.
6
Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.乙酰胆碱诱发的狭窄部位的冠状动脉痉挛预示着伴有冠状动脉痉挛性心绞痛的患者预后不良。
J Am Coll Cardiol. 2015 Sep 8;66(10):1105-15. doi: 10.1016/j.jacc.2015.06.1324.
7
Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013).变异性心绞痛（冠状动脉痉挛性心绞痛）患者的诊断和治疗指南（日本循环学会2013年版）
Circ J. 2014;78(11):2779-801. doi: 10.1253/circj.cj-66-0098. Epub 2014 Sep 30.
8
Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association.血管痉挛性心绞痛患者的预后分层：日本冠状动脉痉挛协会制定的综合临床风险评分。
J Am Coll Cardiol. 2013 Sep 24;62(13):1144-53. doi: 10.1016/j.jacc.2013.07.018. Epub 2013 Jul 31.
9
Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.冠状动脉内乙酰胆碱注射后血管舒缩反应、临床特征及 873 例冠状动脉痉挛患者的长期预后：单中心 20 年研究分析。
J Am Heart Assoc. 2013 Jul 15;2(4):e000227. doi: 10.1161/JAHA.113.000227.
10
Long-term prognosis for patients with variant angina and influential factors.变异型心绞痛患者的长期预后及影响因素
Circulation. 1988 Jul;78(1):1-9. doi: 10.1161/01.cir.78.1.1.
Zotero 插件